Dermatology Online Journal · 2008 · 13 citations · 0 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyControlled Release FormulationsDrug DeliveryAdverse Drug Event PreventionEnteric-coated CapsulesImmediate-release Dosage FormsModified-release FormulationsParenteral FormulationsSustained Release FormulationsDelayed-release Formulation EvaluationDelayed-release FormulationsEnteric Capsule FormulationImmediate-release Oral FormulationsMycophenolate PharmacokineticsMycophenolic Acid TherapyRapid Onset FormulationTablets
Myfortic is a new formulation of mycophenolic acid (MPA) utilizing enteric coated mycophenolate sodium (EC-MPS) that may have fewer gastrointestinal side effects.